UPK1B and cancer: Within pT2-4 carcinomas, only 11.2% of 706 Upk1a positive cancers were Upk1b negative while 41.2% of 1,076 Upk1b positive cancers were Upk1a negative (p < 0.0001; Fig. 3A).